New spin-out launched from Department of Chemistry

Enabling pharmaceutical industries to develop life-saving medicines and securing the future of UK chemistry research are the two main focuses of a new spin-out company launched today by the University of Sheffield and the University of Leeds.

Formed with input from industry leaders, the spin-out, Redbrick Molecular Ltd, will partner closely with universities to identify commercially valuable chemistry before licensing and manufacturing compounds for use in industrial drug discovery research and development. The company will then dedicate all its profits to support further UK chemistry research through grant funding projects at its member institutions.

Professor Dave Petley, Vice-President for Research and Innovation at the University of Sheffield said: “Universities are always seeking novel ways to translate research into industry-ready tools. I am delighted that Sheffield is a partner in Redbrick Molecular’s pioneering approach to commercialisation, which is inspirational and offers an innovative way to fund future academic research.”

Professor Simon Jones, Professor of Chemistry at the University of Sheffield and member of the Science Advisory Group said: “This is a great opportunity to showcase the innovative science going on in UK chemistry departments and to clearly demonstrate the commercial impact at an international level.”

Redbrick is specifically designed to act as a conduit between academic and industrial research. It focuses on delivering industrial-grade products that are attractive to medicinal chemists working in research and development whilst supporting our academic partners to develop exciting new chemistry.

If you have ideas of your own that you would like to develop in a commercial context, the Faculty’s Knowledge Exchange team is available to help. Contact in the first instance.

You could also contact the Faculty’s Commercialisation Manager, Andy Hogben, via 0114 222 0999 or